MétaCan
Menu
Back to cohort
Record W4386028743 · doi:10.1186/s13012-023-01290-3

Reporting of costs and economic impacts in randomized trials of de-implementation interventions for low-value care: a systematic scoping review

2023· article· en· W4386028743 on OpenAlexaff
Petra Falkenbach, Aleksi Raudasoja, Robin W.M. Vernooij, Jussi M. J. Mustonen, Arnav Agarwal, Yoshitaka Aoki, Marco H. Blanker, Rufus Cartwright, Herney Andrés García‐Perdomo, Tuomas P. Kilpeläinen, Olli Lainiala, Tiina Lamberg, Olli Nevalainen, Eero Raittio, Patrick O. Richard, Philippe D. Violette, Kari A.O. Tikkinen, Raija Sipilä, Miia Turpeinen, Jorma Komulainen

Bibliographic record

VenueImplementation Science · 2023
Typearticle
Languageen
FieldHealth Professions
TopicHealthcare cost, quality, practices
Canadian institutionsCentre Hospitalier Universitaire de SherbrookeMcMaster UniversityImpact
FundersStrategic Research Council
KeywordsMedicineHealth administrationHealth services researchHealth economicsPsychological interventionRandomized controlled trialHealth informaticsPublic healthValue (mathematics)Health careSystematic reviewMEDLINENursingEconomic growthEconomicsInternal medicine

Abstract

fetched live from OpenAlex

BACKGROUND: De-implementation of low-value care can increase health care sustainability. We evaluated the reporting of direct costs of de-implementation and subsequent change (increase or decrease) in health care costs in randomized trials of de-implementation research. METHODS: We searched MEDLINE and Scopus databases without any language restrictions up to May 2021. We conducted study screening and data extraction independently and in duplicate. We extracted information related to study characteristics, types and characteristics of interventions, de-implementation costs, and impacts on health care costs. We assessed risk of bias using a modified Cochrane risk-of-bias tool. RESULTS: We screened 10,733 articles, with 227 studies meeting the inclusion criteria, of which 50 included information on direct cost of de-implementation or impact of de-implementation on health care costs. Studies were mostly conducted in North America (36%) or Europe (32%) and in the primary care context (70%). The most common practice of interest was reduction in the use of antibiotics or other medications (74%). Most studies used education strategies (meetings, materials) (64%). Studies used either a single strategy (52%) or were multifaceted (48%). Of the 227 eligible studies, 18 (8%) reported on direct costs of the used de-implementation strategy; of which, 13 reported total costs, and 12 reported per unit costs (7 reported both). The costs of de-implementation strategies varied considerably. Of the 227 eligible studies, 43 (19%) reported on impact of de-implementation on health care costs. Health care costs decreased in 27 studies (63%), increased in 2 (5%), and were unchanged in 14 (33%). CONCLUSION: De-implementation randomized controlled trials typically did not report direct costs of the de-implementation strategies (92%) or the impacts of de-implementation on health care costs (81%). Lack of cost information may limit the value of de-implementation trials to decision-makers. TRIAL REGISTRATION: OSF (Open Science Framework): https://osf.io/ueq32 .

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.258
metaresearch head score (Gemma)0.667
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch
Consensus categoriesMetaresearch
DomainCandidate signal: Reporting · Consensus signal: none
Study designCandidate signal: Systematic review · Consensus signal: Systematic review
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.742
Threshold uncertainty score0.915

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.2580.667
Meta-epidemiology (narrow)0.0040.004
Meta-epidemiology (broad)0.0230.022
Bibliometrics0.0290.025
Science and technology studies0.0020.005
Scholarly communication0.0120.011
Open science0.0060.006
Research integrity0.0070.005
Insufficient payload (model declined to judge)0.0070.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.851
GPT teacher head0.757
Teacher spread0.094 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; the direct Gemma label and the distilled Codex classifier agree on what is shown here.

Study designSystematic review
DomainReporting
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations6
Published2023
Admission routes1
Has abstractyes

Explore more

Same venueImplementation ScienceSame topicHealthcare cost, quality, practicesFrench-language works237,207